Compare OUST & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OUST | SMTI |
|---|---|---|
| Founded | 2015 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 313.5M |
| IPO Year | 2020 | 2008 |
| Metric | OUST | SMTI |
|---|---|---|
| Price | $35.18 | $34.96 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | ★ $39.25 | $34.00 |
| AVG Volume (30 Days) | ★ 2.2M | 325.8K |
| Earning Date | 05-05-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 48.56 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $169,384,000.00 | $15,586,976.00 |
| Revenue This Year | $33.20 | $17.31 |
| Revenue Next Year | $37.27 | $12.48 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 52.46 | 32.47 |
| 52 Week Low | $16.40 | $16.05 |
| 52 Week High | $63.79 | $35.70 |
| Indicator | OUST | SMTI |
|---|---|---|
| Relative Strength Index (RSI) | 43.31 | 78.05 |
| Support Level | $35.30 | $33.99 |
| Resistance Level | $49.39 | N/A |
| Average True Range (ATR) | 1.71 | 0.26 |
| MACD | -0.04 | -0.26 |
| Stochastic Oscillator | 35.72 | 93.10 |
Ouster Inc is a provider of lidar sensors for the automotive, industrial, robotics, and smart infrastructure industries. Ouster's products include high-resolution scanning and solid-state digital lidar sensors, Velodyne Lidar sensors, and software solutions. The company operates in the Americas, Asia and the Pacific, Europe, the Middle East, and Africa. It derives maximum revenue from the Americas. The Company operates as one reportable and operating segment, which relates to the sale and production of lidar sensor kits.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.